Blog

44 Articles

microscope U liverpool
Research
December 2, 2021 • 4 Min

Two New Immunotherapy Trials Aim to Make Therapy More Effective

Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.

Dr. Elizabeth Jaffee
Research
November 4, 2021 • 5 Min

New Clinical Accelerator Initiative Shortens Time from Bench to Clinic

Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.

vaccine vial and syringe
Research
October 27, 2021 • 2 Min

A Vaccine To Boost Immune Response to Pancreatic Cancer

Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.

COVID-19 vaccine vial and syringe
News
March 26, 2021 • 4 Min

Should Cancer Patients Get the COVID-19 Vaccine? Yes!

Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.

computer rendering of KRAS protein structure
Research
March 10, 2021 • 3 Min

A New Vaccine for Advanced Pancreatic Cancer

An mRNA vaccine that works against KRAS mutations is being tested with and without immunotherapy for advanced or metastatic pancreatic cancer.

Pancreatic cancer survivor Gary Carmichael and his wife Floy on their trip to Alaska after
Survivor Stories
June 16, 2020 • 9 Min

Facing My Biggest Danger: Pancreatic Cancer

After Gary Carmichael finally found the source of his digestive troubles, he had a Whipple procedure to remove his pancreatic cancer.

Dr. Beatriz Carreno
Research
April 16, 2020 • 5 Min

Targeting Mutant KRAS with Immunotherapy

Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos
Research
March 23, 2020 • 6 Min

Challenge Grant Recipients Moving Forward

The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.

computer rendering of DNA in Brown and blue against a black background
Research
March 2, 2020 • 2 Min

Testing the Safety of an Immunotherapy Combination After Surgery

A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.

Dr. Vinod Balachandran
Research
March 13, 2019 • 5 Min

Pancreatic Cancer Exceptional Responders and the Immune System Link

Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.

DNA helix made of multicolor dots on a bright blue background
Research
September 21, 2018 • 2 Min

Personalized Immunotherapy Vaccine for Pancreatic Cancer

Researchers are creating a personalized vaccine to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.

Mary Gillam and her husband and three children standing in front of a Christmas tree.
Survivor Stories
August 21, 2018 • 6 Min

I Have So Much to Live For

Mary Gillam knew that she had to fight after her pancreatic cancer diagnosis. She traveled to where she would get the best treatment and a clinical trial.

Randall Swan
Survivor Stories
August 8, 2018 • 6 Min

Before And After: My Pancreatic Cancer

Randall Swan did his homework on the best treatments and clinical trial options in order to do battle with pancreatic cancer.

Dr. Vinod Balachandran
Research
January 16, 2018 • 3 Min

Neoantigens Provide New Hope for Pancreatic Cancer Treatments

Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.

Dr. Elizabeth Jaffee
Research
November 20, 2017 • 4 Min

Overcoming Challenges to Vaccine Immunotherapy

Dr. Elizabeth Jaffee explains the challenges facing the scientists developing vaccine-based immunotherapy for pancreatic cancer.